Nevro (NYSE: NVRO) reported Q2 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $104.16 million versus the consensus estimate of $107.11 million.

GUIDANCE:

Nevro sees FY2024 revenue of $400-405 million, versus the consensus of $439.9 million and Adjusted EBITDA Guidance to a Range of $(20) Million to $(18) Million.

For earnings history and earnings-related data on Nevro (NVRO) click here.